As of 2025-12-13, the Intrinsic Value of Pliant Therapeutics Inc (PLRX) is -12.90 USD. This PLRX valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.28 USD, the upside of Pliant Therapeutics Inc is -1,107.53%.
Based on its market price of 1.28 USD and our intrinsic valuation, Pliant Therapeutics Inc (PLRX) is overvalued by 1,107.53%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -12.90 - -12.90 | -12.90 | -1,107.53% |
| P/E | (50.55) - (50.86) | (50.55) | -4049.5% |
| DDM - Stable | (31.79) - (150.00) | (90.90) | -7201.2% |
| DDM - Multi | (31.63) - (115.65) | (49.62) | -3976.7% |
| Market Cap (mil) | 102.71 |
| Beta | 1.23 |
| Outstanding shares (mil) | 80.24 |
| Enterprise Value (mil) | 39.41 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.61% |
| Cost of Debt | 5.00% |
| WACC | 6.68% |